Literature DB >> 1331449

Orally active, nonpeptide oxytocin antagonists.

B E Evans1, J L Leighton, K E Rittle, K F Gilbert, G F Lundell, N P Gould, D W Hobbs, R M DiPardo, D F Veber, D J Pettibone.   

Abstract

The first nonpeptide antagonists of the neurohypophyseal hormone, oxytocin (OT) are described. Derivatives of the spiroindenepiperidine ring system, these compounds include L-366,509, an orally bioavailable OT antagonist with good in vivo duration. The potential use of these agents for treatment of preterm labor and their significance as new nonpeptide ligands for peptide receptors are discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1331449     DOI: 10.1021/jm00099a020

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  9 in total

1.  Selectivity of d[Cha4]AVP and SSR149415 at human vasopressin and oxytocin receptors: evidence that SSR149415 is a mixed vasopressin V1b/oxytocin receptor antagonist.

Authors:  Cristiana Griffante; Andrew Green; Ornella Curcuruto; Carl P Haslam; Bryony A Dickinson; Roberto Arban
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

2.  Synthesis and in vitro biological evaluation of carbonyl group-containing inhibitors of vesicular acetylcholine transporter.

Authors:  Simon M N Efange; Anil B Khare; Krystyna von Hohenberg; Robert H Mach; Stanley M Parsons; Zhude Tu
Journal:  J Med Chem       Date:  2010-04-08       Impact factor: 7.446

Review 3.  Hormonal and local regulation of uterine activity during parturition: Part I--The oxytocin system.

Authors:  M Maggi; E Baldi; T Susini
Journal:  J Endocrinol Invest       Date:  1994-10       Impact factor: 4.256

4.  An efficient synthesis of a spirocyclic oxindole analogue.

Authors:  Dawei Teng; Hongxing Zhang; A Mendonca
Journal:  Molecules       Date:  2006-09-14       Impact factor: 4.411

5.  Design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue.

Authors:  A A Patchett; R P Nargund; J R Tata; M H Chen; K J Barakat; D B Johnston; K Cheng; W W Chan; B Butler; G Hickey
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-18       Impact factor: 11.205

6.  Oxytocin Receptor Activation Rescues Opioid-Induced Respiratory Depression by Systemic Fentanyl in the Rat.

Authors:  Allison Doyle Brackley; Glenn M Toney
Journal:  J Pharmacol Exp Ther       Date:  2021-05-14       Impact factor: 4.402

7.  Presynaptic glutamatergic transmission and feedback system of oxytocinergic neurons in the hypothalamus of a rat model of adjuvant arthritis.

Authors:  Teruaki Fujitani; Takanori Matsuura; Makoto Kawasaki; Hitoshi Suzuki; Haruki Nishimura; Kazuhiko Baba; Yoshiaki Yamanaka; Hideo Ohnishi; Yoichi Ueta; Akinori Sakai
Journal:  Mol Pain       Date:  2020 Jan-Dec       Impact factor: 3.395

8.  Oxytocin-mediated social enrichment promotes longer telomeres and novelty seeking.

Authors:  Jamshid Faraji; Mitra Karimi; Nabiollah Soltanpour; Alireza Moharrerie; Zahra Rouhzadeh; Hamid Lotfi; S Abedin Hosseini; S Yaghoob Jafari; Shabnam Roudaki; Reza Moeeini; Gerlinde As Metz
Journal:  Elife       Date:  2018-11-13       Impact factor: 8.140

9.  Synthesis of Spiroindenyl-2-Oxindoles through Palladium-Catalyzed Spirocyclization of 2-Bromoarylamides and Vinyl Bromides.

Authors:  Shuai Yang; Yanghui Zhang
Journal:  Molecules       Date:  2021-12-10       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.